Doug Hunt

Doug Hunt has a strong background in regulatory affairs and quality assurance within the biotechnology and pharmaceutical industries. Doug has held leadership positions in various companies, including ArmaGen Technologies, Baxter Bioscience, Amgen Inc, and Quintiles, Inc.

At ArmaGen Technologies, Doug served as the Vice President of Regulatory Affairs and Quality Assurance. In this role, they developed regulatory strategies for the global development of the company's product pipeline and optimized the quality system to ensure compliance. Doug effectively communicated the company's regulatory strategy to stakeholders.

Prior to that, at Baxter Bioscience, Doug was the Vice President of Global Regulatory Affairs. Doug established long-term visions for the regulatory affairs function and provided leadership to the regulatory team. Doug oversaw the development and execution of global regulatory strategies and advised the company's operating committee and board of directors on regulatory agency actions.

Earlier in their career, Doug worked at Amgen Inc as the Executive Director of Regulatory Affairs and Executive Director of Manufacturing Operations. Here, they led teams in defining manufacturing strategies, advised on regulatory trends, and provided regulatory strategy for research, development, and commercialization.

Lastly, Doug held the position of Executive Director at Quintiles, Inc. There is no specific information regarding their role at this company.

Overall, Doug Hunt has a proven track record of developing regulatory strategies, ensuring compliance, and effectively communicating regulatory information to stakeholders.

Doug Hunt attended the University of Portsmouth from 1981 to 1984, where they pursued a Bachelor of Applied Science (B.A.Sc.) degree in Biology, General.